Navigation Links
Influenza drug delayed

The maker of the only medication approved to treat both major strains of influenza in young children said the drug was not available for the start of this flu season because production problems delayed its distribution. The medication, Tamiflu Oral Suspension product, was supposed to be launched this season. Hoffmann-La Roche informed the FDA of its production problems, but FDA spokeswoman Sharon Jayne said the company was not required to do so. //

Tamiflu is one of two FDA approved drugs in a new class of medications, which attack the virus that causes the flu and stops it from spreading. The other medication, Relenza, is equally effective but can cause more side effects and is more difficult to use since it is inhaled twice a day. Both medications must be used within two days of developing symptoms to be effective.

Tamiflu pills for adults and older children were approved by the U.S. Food and Drug Administration in October 1999 and are available. The liquid formula for children 1 or older was approved in December 2000, but was not available until January 2001. Flu season usually occurs between December and April.

Tamiflu can shorten the duration of the flu by one to two days and reduce major complications such as ear infections and bronchitis. Ear infections, the most common complication in children, can be reduced by 44 percent. Tamiflu can reduce the spread of flu in families. When the first person in a household who developed the flu took the drug as well as all other family members, 63 percent of the households were protected against the flu. The results with this drug are marvelous. Two other flu medications, amantadine and rimantadine, are available but only treat Influenza A.
'"/>




Page: 1

Related medicine news :

1. Chances are high for Avian Influenza virus altering its form
2. Influenza Avian Flu strain has become more contagious and dangerous.
3. A Vaccine for the impending pandemic Avian Influenza
4. Influenza Vaccination for children with neurological or neuromuscular disease
5. Avian Influenza: Government to set up expert committee
6. Resistant Influenza strains creates panic in US
7. Influenza Vaccination For The Elderly
8. Fao Declares Humans Spread Avian Influenza Virus
9. Statins Could Play Important Role In Influenza Pandemic
10. Zoo Animal Succumbs to Avian Influenza in Germany
11. India Says It Is ‘‘Avian Influenza Free Country
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of ... innovative new design of the shoulder pad. The shoulder pad provides optimal support ... your pain while using cold therapy. By utilizing ice and water that is circulated ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... AccentCare, a leader in post-acute health care, have expanded their existing home health ... Home Health. , AccentCare has been operating a joint venture home health company ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... Hair Restoration, has recently contributed a medical article to the newly revamped ... Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Leading pediatric oncology ... in Washington, D.C., for the 49th Congress of the International Society of Paediatric ... President of the Center for Cancer and Blood Disorders at Children’s National, ...
(Date:10/12/2017)... Mich. (PRWEB) , ... October 12, 2017 , ... ... has been named one of Michigan’s 2017 Best and Brightest in Wellness® by ... Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... its MyDario product is expected to appear on The Dr. Oz Show ... Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked off ... The segment features ...
(Date:9/25/2017)...  EpiVax, Inc., a leader in the fields ... announced the launch of EpiVax Oncology Inc., a ... cancer vaccines. EpiVax has provided $500,000 in seed ... technologies to the new precision immunotherapy venture. Gad ... as Chief Executive Officer. Gad brings over 25 ...
(Date:9/22/2017)... ROCKVILLE, Md. , Sept. 22, 2017  As ... by Republican Senators Bill Cassidy (R-LA) and ... Kalorama Information notes that the medical device industry is ... the medical device tax, the 2.3% excise tax on ... Act.  But they also want covered patients, increased visits ...
Breaking Medicine Technology: